Newbiotics, Inc.
Records under this name other than patents Newbiotics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,601,703 | Enzyme Catalyzed Therapeutic Agents Formerly held Term ended Ended no later than Sep 16, 2021 · Medium confidence | Term ended | Ended no later than Sep 16, 2021 | Medium confidence |
| US 7,462,605 | Phosphoramidate compounds and methods of use Formerly held Lapsed on the fee record Ended Dec 9, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 9, 2020 | From the USPTO record |
| US 6,245,750 | Enzyme catalyzed therapeutic agents Formerly held Term ended Term ended Jan 22, 2019 · From the USPTO record | Term ended | Term ended Jan 22, 2019 | From the USPTO record |
| US 6,339,151 | Enzyme catalyzed therapeutic agents Formerly held Term ended Term ended Jan 22, 2019 · From the USPTO record | Term ended | Term ended Jan 22, 2019 | From the USPTO record |
| US 7,163,923 | Peptide deformylase activated prodrugs Formerly held Lapsed on the fee record Ended Jan 16, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jan 16, 2019 | From the USPTO record |
| US 6,159,706 | Application of enzyme prodrugs as anti-infective agents Formerly held Term ended Term ended Dec 18, 2018 · From the USPTO record | Term ended | Term ended Dec 18, 2018 | From the USPTO record |
| US 7,138,388 | Methods to treat autoimmune and inflammatory conditions Formerly held Lapsed on the fee record Ended Nov 21, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 21, 2018 | From the USPTO record |
| US 6,495,553 | Methods and compositions for overcoming resistance to biologic and chemotherapy Formerly held Term ended Term ended Aug 7, 2018 · From the USPTO record | Term ended | Term ended Aug 7, 2018 | From the USPTO record |
| US 7,001,922 | Peptide deformylase activated prodrugs Lapsed on the fee record Ended Feb 21, 2018 · From the USPTO record | Lapsed on the fee record | Ended Feb 21, 2018 | From the USPTO record |
| US 7,605,144 | Enzyme catalyzed therapeutic compounds Formerly held Lapsed on the fee record Ended Oct 20, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 20, 2017 | From the USPTO record |